title: Adiponectin as a biomarker of the metabolic syndrome in children and adolescents.
abstract: The prevalence of obesity in children and adolescents has been increasing worldwide. As in adults, childhood obesity is closely related to hypertension, dyslipidemia, type 2 diabetes, and insulin resistance (IR) syndrome. Moreover, obese children have been found to be at increased risk of becoming obese adults. Obese children and adolescents tend to develop serious medical and psychosocial complications and also are at greater risk morbidity and mortality in adulthood. The molecular basis of the pathogenesis of obesity-linked disorders has not been fully elucidated. Adipose tissue serves not only as an energy storage organ, but also as an endocrine organ. It releases many factors with autocrine, paracrine and endocrine functions. Adipokines such as leptin, resistin, tumor necrosis factor-α, interleukin-6, adipsin, visfatin, and adiponectin are biologically active molecules produced by adipose tissue. They play a role in energy homeostasis, and in glucose and lipid metabolism. Adiponectin level, unlike that of other adipocytokines, is decreased in obesity and increased after weight reduction. Adiponectin has been associated with both central obesity and increased visceral adipose tissue and it has anti-inflammatory, anti-atherogenic, and potent insulin-sensitizing (anti-diabetic) effects.
authors.affiliation: Department of Pediatrics and Endocrinology, Medical University of Warsaw, Warsaw, Poland. beata.pyrzak@wum.edu.pl
authors.forename: Beata
authors.initials: B
authors.lastname: Pyrzak
authors.forename: M
authors.initials: M
authors.lastname: Ruminska
authors.forename: K
authors.initials: K
authors.lastname: Popko
authors.forename: U
authors.initials: U
authors.lastname: Demkow
mesh_terms: D052242:Adiponectin / Q000097:blood* / Q000737:chemistry; D000293:Adolescent; D000818:Animals; D015415:Biomarkers; D015992:Body Mass Index; D002648:Child; D047109:Fetal Development; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000175:diagnosis*
chemical_list: D052242:Adiponectin; D015415:Biomarkers